# Cytek Biosciences, Inc. (CTKB) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$40M |
| 2024 | -$21M |
| 2023 | -$28M |
| 2022 | -$2M |
| 2021 | $9M |
| 2020 | $14M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$18M |
| 2025-09-30 | -$9M |
| 2025-06-30 | -$11M |
| 2025-03-31 | -$15M |
| 2024-09-30 | -$4M |
| 2024-06-30 | -$9M |
| 2024-03-31 | -$11M |
| 2023-09-30 | -$6M |
| 2023-06-30 | -$9M |
| 2023-03-31 | -$12M |
| 2022-09-30 | $1M |
| 2022-06-30 | -$891,000 |
| 2022-03-31 | -$2M |
| 2021-09-30 | $3M |
| 2021-06-30 | $4M |
| 2021-03-31 | $1M |
| 2020-09-30 | $7M |
| 2020-06-30 | -$218,000 |

Source: [CompaniesByCap](https://companiesbycap.com/company/CTKB/operating-income)